Would 25% albumin exacerbate hypo-osmolar hyponatremia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

No, 25% albumin would not worsen hypo-osmolar hyponatremia and may actually help in certain situations, as supported by the most recent guidance from the American Association for the Study of Liver Diseases in 2021 1. Albumin is an oncotically active protein that draws fluid into the intravascular space without significantly affecting serum sodium concentration. When 25% albumin is administered, it increases oncotic pressure in the blood vessels, which can help pull excess free water from the interstitial and intracellular spaces into the vasculature, potentially allowing for more effective removal of this free water through diuresis. This differs from hypotonic fluids like 5% dextrose or even isotonic saline, which can worsen hyponatremia by adding more free water relative to sodium.

Key Considerations

  • In patients with hyponatremia associated with volume depletion or conditions like cirrhosis, 25% albumin may be beneficial as part of the treatment strategy, as indicated by recent practice guidance 1.
  • Albumin alone is not a primary treatment for hyponatremia - addressing the underlying cause and potentially using hypertonic saline (3% NaCl) for severe symptomatic cases remains essential.
  • The dose of albumin typically ranges from 25-50g (100-200mL of 25% solution) administered intravenously, but should be tailored to the specific clinical situation.
  • Water restriction and cessation of diuretics are also recommended in the management of moderate to severe hyponatremia, with more severe restriction and albumin infusion considered for severe cases 1.

Clinical Context

The use of 25% albumin in the context of hypo-osmolar hyponatremia should be guided by the most recent clinical practice guidelines, which emphasize a cautious approach to correcting serum sodium levels to avoid osmotic demyelination syndrome (ODS) 1. The goal rate of increase of serum sodium is 4-6 mEq/L per 24-hour period, not to exceed 8 mEq/L per 24-hour period, as recommended by the American Association for the Study of Liver Diseases 1.

From the Research

Hypo-Osmolar Hyponatremia and 25% Albumin

  • The use of 25% albumin in the treatment of hypo-osmolar hyponatremia is not directly addressed in the provided studies 2, 3, 4, 5, 6.
  • However, it is known that hypo-osmolar hyponatremia is characterized by a low serum osmolality and a low serum sodium concentration.
  • The treatment of hypo-osmolar hyponatremia typically involves correcting the underlying cause of the disorder, such as fluid restriction, hypertonic saline, or vasopressin receptor antagonists 2, 3, 4, 5, 6.
  • The use of 25% albumin could potentially worsen hypo-osmolar hyponatremia if it increases the amount of free water in the body, leading to a further dilution of serum sodium.
  • It is essential to monitor serum sodium levels closely and adjust treatment accordingly to avoid overly rapid correction, which can lead to osmotic demyelination 2, 5, 6.

Treatment of Hyponatremia

  • The treatment of hyponatremia depends on the severity of symptoms, the underlying cause, and the presence of other electrolyte imbalances 2, 3, 4, 5, 6.
  • Hypertonic saline is commonly used to treat moderate to severe hyponatremia, especially in patients with symptoms such as seizures or coma 3, 5, 6.
  • Vasopressin receptor antagonists, such as vaptans, are also used to treat hyponatremia, particularly in patients with SIADH or other forms of vasopressin-induced hyponatremia 2, 4, 5.
  • Fluid restriction is often used in combination with other treatments to manage hyponatremia, especially in patients with mild to moderate symptoms 2, 3, 4, 5, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical management of SIADH.

Therapeutic advances in endocrinology and metabolism, 2012

Research

Hypertonic Saline for Hyponatremia: Meeting Goals and Avoiding Harm.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2022

Research

Evaluation and management of hypo-osmolality in hospitalized patients.

Endocrinology and metabolism clinics of North America, 2003

Research

Hyponatremia: A Review.

Journal of intensive care medicine, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.